Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Cash & Current Investments (2022 - 2025)

Historic Cash & Current Investments for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $4.5 billion.

  • GE HealthCare Technologies' Cash & Current Investments rose 5606.64% to $4.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.5 billion, marking a year-over-year increase of 5606.64%. This contributed to the annual value of $4.5 billion for FY2025, which is 5606.64% up from last year.
  • According to the latest figures from Q4 2025, GE HealthCare Technologies' Cash & Current Investments is $4.5 billion, which was up 5606.64% from $4.0 billion recorded in Q3 2025.
  • In the past 5 years, GE HealthCare Technologies' Cash & Current Investments registered a high of $4.5 billion during Q4 2025, and its lowest value of $504.0 million during Q3 2022.
  • Its 4-year average for Cash & Current Investments is $2.4 billion, with a median of $2.4 billion in 2023.
  • In the last 5 years, GE HealthCare Technologies' Cash & Current Investments soared by 38015.87% in 2023 and then crashed by 346.98% in 2025.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' Cash & Current Investments stood at $1.5 billion in 2022, then skyrocketed by 72.71% to $2.5 billion in 2023, then grew by 15.44% to $2.9 billion in 2024, then soared by 56.07% to $4.5 billion in 2025.
  • Its Cash & Current Investments stands at $4.5 billion for Q4 2025, versus $4.0 billion for Q3 2025 and $3.8 billion for Q2 2025.